发明名称 |
ALPHA-2 ADRENERGIC AGONIST FOR TREATING INTRAOCULAR PRESSURE AND OCULAR DISEASES THROUGH INTRAVITREAL AND INTRACAMERAL ROUTES |
摘要 |
The present invention provides a method of lowering intraocular pressure which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin-2-ylamino)benzimidazole, or a salt thereof to the affected eye of a patient, as a single dose, wherein the affected eye has an intraocular pressure less than the baseline. |
申请公布号 |
US2014275197(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
US201414206746 |
申请日期 |
2014.03.12 |
申请人 |
Allergan, Inc. |
发明人 |
DIBAS Mohammed I.;GIL Daniel W.;DONELLO John E. |
分类号 |
A61K31/4184;A61K9/00 |
主分类号 |
A61K31/4184 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of lowering intraocular pressure which comprises administering by direct injection into the eye a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5-(2-imidazolin2-ylamino)benzimidazole or a salt thereof, to the affected eye of a patient, in need thereof, as a single dose. |
地址 |
Irvine CA US |